Aytu Bioscience (AYTU): Explosive 40% upside potential on earnings report

Investors and analysts are very bullish on Aytu Bioscience (AYTU). According to Zacks Investment Research they could report positive results.

AYTU is committed to better health for men, women, and children here at home and worldwide. We’re an emerging specialty pharmaceutical company focused on commercializing novel products that address significant patient needs. And we will seek to expand and grow into other significant conditions with novel treatments. Above all, AYTU is dedicated to better health and better living for the patients we serve.

On May 14, 2020 AYTU is due to report their earnings. Analysts expect this company to report quarterly loss of $0.39 per share in its upcoming report, which represents a year-over-year change of +22%. Analysts also expect revenues to be up 195% or $9 million from the previous year.

Aytu Bioscience (AYTU) Stock Snapshot

AYTU stock preivously closed at $1.47 per share with an open price of $1.45 per share. The day’s range spans from $1.45 to $1.50 with 52 week range spanning from $0.34 to $3.

Today’s volume is above 1,200,000 shares with average volume of 25,000,000 shares. Wall Street analysts predicts that in 1 year AYTU stock could reach a price of $4+.

Just recently AYTU stock has outpaced the market by 1.30% and most analysts are rating it a strong buy due to potential surprises for the upcoming earnings report.

Conclusion: Should you buy Aytu Bioscience (AYTU) Stock?

At its current share price, Aytu Bioscience could be an excellent long-term investment with a very generous yield and solid growth prospects. The majority of the metrics point to this investment being highly attractive.

Default image
Jay Lorrence
Investor of 12 years and Managing Editor of Money Midnight, a news outlet focused on highly profitable investment ideas and bold underground research.
Articles: 231

Newsletter Updates

Enter your email address below to subscribe to our newsletter